Transcriptional activation by the tumor suppressor p53 is regulated at multiple levels, including posttranslational modi®cations of the p53 protein, interaction of p53 with various regulatory proteins, or at the level of sequencespeci®c DNA binding to the response elements in p53's target genes. We here propose as an additional regulatory mechanism that the DNA topology of p53-responsive promoters may determine the interaction of p53 with its target genes. We demonstrate that sequencespeci®c DNA binding (SSDB) and transcriptional activation by p53 of the mdm2 promoter is inhibited when this promoter is present in supercoiled DNA, where it forms a non-B-DNA structure which spans the p53-responsive elements. Relaxation of the supercoiled DNA in vitro resulted in conversion of the non-B-DNA to a B-DNA conformation within the mdm2 promoter, and correlated with an enhanced SSDB of p53 and an elevated expression of a reporter gene. In contrast, sequence speci®c DNA binding and transcriptional activation of the p21 promoter were not inhibited by DNA supercoiling. We propose that conformational alterations within p53-responsive sites, which either promote or prohibit sequence speci®c DNA binding of p53, are an important feature in orchestrating the activation of dierent p53 responsive promoters.
Introduction
The ability to activate the expression of target genes is a fundamental property of the tumor suppressor p53 that de®nes a cell's destiny upon genotoxic assaults. The variety of functions associated with the products of dierent p53-inducible genes (Wang and Ohnishi, 1997) will lead to quite dierent cellular responses, such as growth arrest or apoptosis, depending on the cellular system and the type of stimuli. This requires that transcriptional activation of the various target genes by p53 must be orchestrated according to the needs for particular gene products in a given cellular environment. Several lines of evidence obtained in dierent experimental systems support the hypothesis of cell-and event-speci®c p53 responses. Comparative analyses of the expression patterns of the p21 (waf1/ cip1) (El-Deiry et al., 1993) and the mdm2 gene (Barak et al., 1993; Wu et al., 1993) indicate that the induction of wild type p53 in mouse embryos by g-irradiation resulted in selective transactivation of the mdm2 gene (Luna et al., 1997) , whereas transcription of the p21 gene was not activated by p53 in this system. The alternate expression of the p21 and mdm2 genes was also reported during the course of CMV infection (Garcia et al., 1997) . Not only the induction of dierent target genes by p53, but also the activation of the same gene may be subject to temporal regulation within the same cells, depending on stimuli applied. As an example, the dierential and dose-dependent activation of the p53-speci®c (P2) promoter within the mdm2 gene in response to UV irradiation has been reported (Saucedo et al., 1998) . The decision for the induction of dierent target genes by p53 most likely occurs at the level of the interaction of p53 with DNA, since sequence-speci®c DNA binding (SSDB) of p53 is a prerequisite for its transactivating potential (Kern et al., 1991) . Indeed, selective binding of p53 to dierent p53 response elements has been observed in vivo (Chin et al., 1997) and in vitro (Di Como and Prives, 1998) , consistent with the idea that p53 can discriminate between its target DNA binding sites. SSDB of p53 is complex and regulated at multiple levels. Posttranslational modi®cations of the p53 protein (Wang and Prives, 1995; Shaw et al., 1996; Gu and Roeder, 1997) or its interaction with regulatory proteins, like REF1, HMG1, p300, or p33ING (Jayaraman et al., 1997 (Jayaraman et al., , 1998 Lill et al., 1997; Garkavtsev et al., 1998) enhance SSDB and the ability of p53 to activate transcription. However, in spite of this considerable progress in elucidating the factors that modulate sequence-speci®c transactivation by p53, it still remains unclear, what determines the selectivity toward dierent p53-responsive promoters. As a fairly new aspect it recently has emerged that the interaction of p53 with DNA may also depend on DNA topology.
We previously reported that p53 is able to discriminate between p53 binding sites present in dierent DNA conformations, and that some of the non-B-DNA conformations enhanced, while others inhibited SSDB to arti®cially generated topological isoforms of these sites (Kim et al., 1997) . These observations indicate that p53 is able to recognize non-B-DNA structures in vitro. Topological features of the promoter DNA thus may serve as structural determinants for speci®c interactions of p53 with its cognate sites. However, until now no experimental evidence is available which would directly demonstrate the physiological signi®cance of DNA topologydependent SSDB and its potential role in transcriptional activation of target genes by p53. In this paper we demonstrate that topological properties of the promoter DNA may determine not only the strength, but most importantly the selectivity of transactivation by p53 of dierent target genes, as these DNAs may adopt conformations within the individual promoters which either promote or prohibit DNA binding.
Results
The major aim of this study was to examine whether DNA topology might be a determinant for SSDB and transactivation by p53. As gene expression analyses had suggested that the p21 and the mdm2 genes could be dierentially induced by p53 in vivo (Luna et al., 1997; Garcia et al., 1997; Saucedo et al., 1998) , we examined SSDB of immunopuri®ed p53 protein to the p21 and the mdm2 (P2) promoters and correlated it with p53-dependent transactivation of these promoters, measured in reporter assays. The topology of supercoiled DNA may dier strikingly from the topology of linear DNA fragments or duplex oligonucleotides. Therefore, in addressing the relevance of promoter DNA topology for SSDB and transactivation by p53 it was of critical importance to use the same DNA templates both in DNA binding and in transactivation assays. We constructed the reporter plasmids p21-G13 and mdm2-G13, where the luciferase reporter gene is driven by the authentic p21 (El-Deiry et al., 1993), or mdm2 (P2) (Zauberman et al., 1995) promoters, respectively. This allowed us to compare p53-speci®c transactivation of these promoters independently from dierences in vector backbones. Transactivation was measured in transient co-expression assays, where supercoiled p21-G13 or mdm2-G13 DNA was cotransfected with the wtp53 expression vector pCDNA3-wtp53 (Rowan et al., 1996) into the p53-null cells Saos-2 and G-130. Although both the p21 and the mdm2 (P2) promoter were eciently induced in a p53-dependent manner, the p21 promoter was activated to a much higher extent in both cell lines than the mdm2 (P2) promoter (Table 1 , shown for Saos-2 cells). To test whether the dierent response re¯ected dierences in the interaction of the p53 protein with these two promoters, we analysed the binding of immunopuri®ed p53 protein to supercoiled p21-G13 or mdm2-G13 DNAs in DNaseI protection assays. We observed marked dierences in the binding of the p53 protein to supercoiled DNAs containing the p21 or mdm2 (P2) promoters (Figure 1 ). Whilst 80 ng of p53 protein was sucient to completely protect the p53 binding site within the p21 promoter ( Figure 1a , lane 3), no protection of the p53 binding sites within the mdm2 (P2) promoter could be detected in the presence of 80 ng, or even 160 ng p53 protein ( Figure 1b , lanes 2 and 4, correspondingly). In striking contrast to these data were the results of experiments in which linear DNA fragments containing p53 binding sites from the p21 and the mdm2 (P2) promoters, obtained by restriction digestion of the p21-G13 or mdm2-G13 plasmids, were tested as binding substrates in DNaseI protection assay. Figure 1b reveals that the two p53 binding sites (the 5'-and the 3'-site) within the linear mdm2 (P2) promoter were fully protected already in the presence of 80 ng of p53 protein (Figure 1b, lane 11) indicating that linearized mdm2X (P2) promoter DNA is a much better binding substrate for p53 than supercoiled mdm2 (P2) promoter DNA. To exclude the possibility that single-stranded DNA ends of the linearized mdm2 (P2) promoter DNA stimulated SSDB to this DNA (Jayaraman and Prives, 1995) , the p21-G13 or mdm2-G13 plasmids were relaxed by topoisomerase I, and then subjected to DNaseI protection. If DNA relaxation rather than free ends enhance SSDB, then relaxed and covalently closed DNA resulting from topoisomerase I treatment should also be a preferred substrate for p53. Indeed, treatment of DNA with topoisomerse I drastically enhanced SSDB of p53 to the mdm2 (P2) promoter (Figure 1b , lanes 6 ± 8), as p53 binding sites in the relaxed DNA were fully protected already in the presence of 80 ng of p53 protein ( Figure 1b, lane 8 ). These results demonstrate that p53 is able to bind to the mdm2 (P2) promoter equally well as it binds to the p21 promoter. We thus assume that the mdm2 (P2) promoter in supercoiled DNA adopts conformational features that render it an unfavorable binding substrate for p53 as compared to relaxed DNA. In contrast, the interaction of p53 with the p21 promoter was not aected by supercoiling, and the p53 protein bound equally well to the p21 promoter regardless of whether supercoiled ( Figure 1a , lanes 1 ± 3), relaxed ( Figure 1a , lanes 4 ± 6), or linearized ( Figure  1a , lanes 7 ± 10) DNA was oered as a substrate.
As PAb421 is known to activate SSDB of p53 (Hupp et al., 1992) , we also tested the eect of this antibody in our binding experiments. However, PAb421 did not enhance SSDB to the mdm2 (P2) promoter in supercoiled DNA (Figure 1b , lanes 3 and 5), and neither did PAb421 stimulate binding of p53 to any (p21-G13, Figure 1a , lane 10; or mdm2-G13, Figure 1b , lanes 3, 5 and 12) of the DNAs tested in DNaseI protection assays. The lack of activation in DNaseI protection experiments was not due to the presence of saturating amounts of p53 protein in these experiments, as we observed a strong stimulation of DNA binding by PAb421 in EMSA experiments with the same DNA fragments and with the same amounts of p53 protein that were used in DNaseI protection experiments (Figure 1c) . Here, PAb421 strongly activated SSDB (Figure 1c , lanes 4 and 9) which otherwise (in the absence of PAb421) was not detectable at all (Figure 1c , lanes 1 ± 3 and 6 ± 8). As the same DNA fragments, and the same preparations Saos-2 cells were transiently transfected with 4 mg of supercoiled reporter plasmid DNA, with (+wtp53) or without (control) 0.1 mg of the co-transfected pCDNA3-wtp53 (Rowan et al., 1996) . Results are mean+s.e.m. shown for the representative experiment performed in triplicate
Promoter DNA topology determines the interaction of p53 with its target genes E Kim et al of p53 protein and PAb421 were used both in DNaseI protection experiments (Figure 1a ,b) and in EMSA ( Figure 1c ), and as both assays were performed under identical reaction conditions (see Materials and methods), the striking discordance in binding behavior must result from the dierent processing of the pre- Figure 1 Comparison of SSDB by p53 to the mdm2 (P2) and p21 promoters in supercoiled, circular relaxed or linear forms. 0.1 mg of supercoiled (sc) or relaxed (rel) p21-G13 (a, lanes 1 ± 6), or mdm-G13 (b, lanes 1 ± 8) plasmid DNA were incubated with the indicated amounts of p53 protein, and with (+) or without (7) PAb421 and subjected to DNaseI digestion. For testing linear substrates in DNaseI protection experiments (a, lanes 7 ± 10 and b, lanes 9 ± 12), 304 bp or 80 bp DNA fragments were isolated from the mdm2-G13 or p21-G13 DNAs, respectively, as described in Materials and methods, incubated with the indicated amounts of p53 protein, with (+) or without (7) PAb421 and subjected to DNaseI digestion. The same DNA fragments were radiolabeled and tested for binding by p53 in EMSA assays (c). The two p53 binding sites within the mdm2 (P2) promoter are referred to as 5'-and 3'-sites, re¯ecting their positions relative to the transcription initiation site. p53 binding sites from the mdm2 (P2) or the p21 promoter are indicated by parenthesis. Positions of shifted and free DNA probes are indicated by arrows and designated as S or FP, respectively. Relaxation of DNA was achieved by treatment with topoisomerase I as described in Materials and methods formed p53-DNA complexes in these two assays. We interpret these data as to indicate that p53 binds to its binding sites in the mdm2 (P2) and the p21 promoters in linear DNA already in the absence of PAb421 allowing ready detection of the resulting DNA-p53 complexes in DNaseI protection assays. In EMSA, however, these complexes are not stable and dissolve during electrophoresis unless PAb421 is added. PAb421 thus seems to further stabilize SSDB of p53 by enhancing the anity of p53 to the DNA substrate. The ®nding that p53 did not bind to the mdm2 promoter in supercoiled DNA even in the presence of PAb421 supports the conclusion that this promoter is not accessible to p53 under these conditions, possibly due to this promoter adopting a non-B-DNA conformation which does not allow p53 binding. Interestingly, p53-DNA complexes containing the p21 substrate in the presence of PAb421 migrated as a single shifted band (Figure 1 , lane 9, indicated by arrow) [the faster migrating band that appeared in the presence of higher amounts of p53 ( Figure 1 , lanes 8 and 9) represents unspeci®c DNA binding as con®rmed by DNA competition experiments (not shown)], while two complexes with diering mobility were formed with the mdm2 (P2) promoter fragment (two major bands S1 and S2 in lane 4). The dierences in the binding pattern of p53 to the p21 and mdm2 (P2) promoter fragments can be explained by dierences in sequence and composition between these two binding sites. The p53 response element in the p21 promoter is a canonical p53 binding site composed of two repeats of the consensus sequence 5'-PuPuPuC(A/T)(T/ A)GPyPyPy-3' (El-Deiry et al., 1993) . In contrast, the mdm2 (P2) promoter contains four repeats of the consensus decamer, which possibly can form two cooperating promoter elements (Zauberman et al., 1995) . Depending on whether only one or both of these two binding sites (designated 5'-or 3'-binding sites, respectively) are occupied by p53 molecules, DNA-p53-PAb421 complexes formed with the mdm2 (P2) promoter fragment will migrate with dierent mobilities. We, thus, assume, that the two shifted bands detected with mdm2 DNA (Figure 1 , lane 4) represent the mdm2 (P2) promoter fragment with partially or fully occupied p53 binding sites, respectively.
The mdm2 (P2) promoter adopts an unusual conformation upon DNA supercoiling Supercoiling is a driving force for transient transitions in DNA conformation and the formation of non-B-DNA structures. Therefore, supercoiling of the mdm2-G13 DNA might have induced conformational distortions within the mdm2 (P2) promoter DNA which prohibited its recognition by p53. A hallmark of non-B-DNA structures is the presence of unpaired bases that can be detected by single-strand, speci®c nucleases (SSN) which are sensitive probes for local melting in supercoiled DNA (Yagil, 1991) . To determine whether such structural transitions might occur within the mdm2 (P2) promoter, we subjected supercoiled mdm2-G13 DNA to SSN analyses as described in Materials and methods. Two dierent enzymes, S1 nuclease and mung bean nuclease, were used to probe the DNA conformation within the mdm2 (P2) promoter. Figure 2a , left panel, reveals that several nuclease-sensitive sites could be detected within the mdm2 (P2) promoter, particularly in close proximity to the p53 binding sites. Despite dierent reaction conditions (see Materials and methods), S1 nuclease and mung bean nuclease both attacked the same sites in supercoiled mdm2-G13 DNA, indicating that the digestion was speci®c for single-stranded DNA regions and could not be attributed to unspeci®c cutting of paired duplex DNA. Some sites were preferentially cut by mung bean nuclease, but not by the S1 nuclease and vice versa, probably re¯ecting dierences in the speci®city of these two enzymes. Few clusters of unpaired bases border the p53 binding sites on the bottom strand (shown by dotted lines along the image), with several single SSN-sensitive bases located within the p53 binding elements themselves (indicated by stars). The SSN-sensitive regions showed an asymmetrical pattern insofar as the SSN-sensitive regions from the bottom strand did not coincide with SSN-sensitive regions in the top strand ( Figure 2a , right panel). As an additional control for speci®city, supercoiled mdm2-G13 DNA was relaxed with topoisomerase I, which should revert any conformational distortions, and thereby render this DNA resistant against SSN cleavage. Analysis of topoisomerase I relaxed mdm2-G13 DNA veri®ed that supercoiling was required for the formation of the detected SSN-sensitive regions, as the relaxed DNA was completely resistant to SSN cleavage (Figure 2a, rel) .
Further evidence for conformational distortions within the mdm2 (P2) promoter was obtained from restriction enzyme mapping experiments, where supercoiled or topologically relaxed mdm2-pG13 DNA was digested with the restriction enzyme PstI. This enzyme was chosen because its a unique recognition site in mdm2-G13 DNA is located within a 17 bp spacer separating the two p53 binding sites, where one of the SSN-sensitive regions had been detected (Figure 2a) . If indeed sensitivity to SSN cleavage in this region resulted from local distortions in DNA conformation, then PstI should not be able to digest supercoiled mdm2-G13 DNA, but should be able to cleave relaxed mdm2-G13 DNA. Treatment of supercoiled mdm2-G13 DNA with PstI indeed corroborated the results of our SSN cleavage analysis (Figure 2b ). When mdm2-pG13 DNA containing both supercoiled and relaxed topoisomers (Figure 2 , lane 1) was incubated overnight with excess PstI (Figure 2, lane 2) , only the fraction of relaxed DNA was completely linearized, whereas the fraction of supercoiled DNA was not digested. That the resistance of supercoiled mdm2-G13 DNA to PstIspeci®c digestion was due to topological features could be further documented, when supercoiled DNA was ®rst relaxed with topoisomerase I and then digested with PstI. Topoisomerase I converted the fraction of supercoiled mdm2-G13 DNA molecules into the relaxed topoisomer (compare lanes 1 and 3) which then was completely cleaved by PstI under the same conditions where supercoiled DNA was not accessible (compare lanes 2 and 4).
We also examined supercoiled and topoisomerase I relaxed p21-G13 DNA for the presence of SSNsensitive bases within or in close vicinity of the p21 promoter. In supercoiled p21-G13 DNA several bases within the p53 binding site showed sensitivity to S1
Promoter DNA topology determines the interaction of p53 with its target genes E Kim et al nuclease ( Figure 3, lanes 2 and 3, sc) . Surprisingly, and in contrast to SSN-sensitive sites within the mdm2 (P2) promoter, relaxation of p21-G13 DNA with topoisomerase I did not completely abolish the sensitivity of this DNA to S1 nuclease treatment (Figure 3 , lanes 4 and 5, rel). One possibility to explain this result is that the conformational transition within the p21 promoter upon supercoiling leads to the formation of an unusually stable non-B-DNA structure that does not dissolve completely upon relaxation of the DNA with topoisomerase I. Although the transition from B-to a non-B-DNA conformation requires energy provided by supercoiling, some structures, once extruded, may remain stable even upon DNA relaxation in a DNA population with a very low superhelical density (Sinden et al., 1983) . Therefore, it is possible that some non-B-DNA structures may persist even after relaxation of DNA, rendering the relaxed DNA sensitive to SSN as reported (Yagil, 1991) . The p53 responsive element within the p21 promoter exhibits a high degree of selfcomplementarity (marked by arrows in Figure 3 ) which renders this sequence capable of self-folding under superhelical stress, forming a cruciform structure. Studies on the kinetics of cruciform extrusion and reabsorption revealed that the reabsorption of cruciform structures formed by self-complementary sequences is very slow even when a cruciformcontaining DNA fragment was cut out of supercoiled DNA (Gellert et al., 1983) . Cruciform extrusion within the p21 promoter thus could explain the high stability of this structure and its persistence after DNA relaxation by topoisomerase I. Our experiments with S1 nuclease suggest that this may be the case, as those bases which would be unpaired in cruciform DNA (indicated by dots in Figure 3) were also sensitive to S1 nuclease (dotted lines).
p53-dependent transactivation of the mdm2 promoter is negatively regulated in supercoiled DNA Our results so far have shown that DNA supercoiling induces structural transitions within the mdm2 (P2) promoter which correlated with an inhibitory eect on the binding of p53 to this promoter. In contrast, DNA Figure 2 Enzymatic mapping of DNA conformation within the mdm2 (P2) promoter. (a) Mapping of the DNA conformation within the mdm2 (P2) promoter with single-stranded DNA-speci®c nucleases. Supercoiled (sc) or topoisomerase I-relaxed mdm2-G13 DNA (rel) were incubated without (lane 1) or with S1 (lanes 2, 5, 7 and 9) or mung bean (lanes 3, 6, 8 and 10) nucleases as described in Materials and methods. Several SSN-sensitive sites were detected within (stars) or in close vicinity (dotted lines) to the p53 binding sites indicated by parenthesis. The unique restriction site for the PstI restriction enzyme overlapping with one of the SSN-sensitive regions close to the 3'-binding site is also indicated. (b) Restriction mapping of structural distortions within the mdm2 (P2) promoter by PstI digestion. Supercoiled (sc), relaxed (rel) or linear (lin) DNA forms were resolved in 0.8% agarose and gels were stained with ethidium bromide supercoiling did not aect SSDB of p53 to the p21 promoter. These results correlated well with the results of our transient transfection experiments performed with supercoiled reporter plasmids, where the coexpressed p53 activated transcription from the mdm2 (P2) promoter to a lesser extent than transcription from the p21 promoter. As SSDB of p53 determines the potential of p53 to transactivate a target gene (Kern et al., 1991) , and as relaxation of supercoiled DNA with topoisomerase I selectively restored ecient binding of p53 to its response elements within the mdm2 (P2) promoter, we postulated that relaxation of the mdm2-G13 DNA should increase transactivation from the mdm2 (P2) promoter. In contrast, transactivation from the p21 promoter should not be aected by changes in DNA topology, as binding of p53 to the p21 promoter in vitro was independent from DNA topology. To test this assumption, supercoiled, nicked or relaxed mdm2-G13 or p21-G13 DNA was cotransfected together with the wtp53-expressing plasmid pCDNA3-wtp53 into Saos-2 and G-130 cells, and activation of the mdm2 (P2) and p21 promoters, respectively, was measured (Figure 4 ). Topoisomerase I was used to relax supercoiled DNA prior to transfection (Materials and methods). To distinguish between the eects of spontaneous DNA nicking and relaxation caused by topoisomerase I, supercoiled DNA in control reactions was also incubated at +378C under the same reaction conditions, but in the absence of topoisomerase I. Treatment of p21-G13 DNA with topoisomerase I led to a decrease in the expression of the reporter gene in both, Saos-2 and G-130 cells (compare black and white hatched bars in Figure 4 , bar group p21-G13). However, a similar reduction was also observed when control supercoiled p21-G13 DNA was preincubated at +378C in the absence of topoisomerase I (grey hatched bars), indicating that the reduction in promoter activity was unspeci®c and due to random nicking during incubation of the DNA at +378C, as con®rmed by analysis of the DNA in agarose gels (data not shown). Prenicked DNA molecules are highly accessible to cleavage by intracellular nucleases, leading to a reduced expression of the transfected reporter gene. From these data we conclude that DNA relaxation with topoisomerase I had no eect on the activation of the p21 promoter by p53.
As with p21-G13 DNA, incubation of the mdm2-G13 DNA at +378C in the absence of topoisomerase I slightly reduced the expression of the reporter gene due to spontaneous nicking of DNA. However, despite the reducing eects of DNA nicking, relaxation of the mdm2-G13 DNA with topoisomerase I signi®cantly enhanced the activation of the mdm2 (P2) promoter by p53 in both cell lines (Figure 4 , black hatched bars, bar group mdm2-G13). Interestingly, activation of the relaxed mdm2 (P2) promoter by p53 was in the same range or even higher (in G-130 cells) as activation of the (relaxed) p21 promoter. We thus conclude that the enhanced activation of the mdm2 (P2) promoter upon relaxation of the mdm2-G13 DNA re¯ects the increased transactivation potential of p53 due to an enhanced binding of p53 to the mdm2 (P2) promoter in relaxed DNA.
Despite signi®cantly enhancing the activation of transcription from the mdm2 (P2) promoter after transient transfection, DNA relaxation had a more pronounced eect on the in vitro binding of p53 to the mdm2 promoter. The dierence could be readily explained by the likely possibility that a signi®cant fraction of the supercoiled mdm2-pG13 DNA will become relaxed within the cells by endogenous topoisomerases. However, we do not want to exclude the alternate possibility that a cellular factor(s) will bind to the mdm2 (P2) promoter in supercoiled mdm2-pG13 DNA and allow binding of p53.
Discussion
p53 is able to activate transcription of a growing number of genes which execute quite dierent and sometimes opposing biological functions (reviewed in Wang and Ohnishi, 1997) . To avoid signaling con¯icts which could result from simultaneous activation of target genes with con¯icting functions, ecient means must exist that ensure selectivity of activation. Despite rapidly accumulating knowledge on various modes of Figure 3 S1 nuclease mapping of the DNA conformation within the p21 promoter. Supercoiled (sc) or topoisomerase I-relaxed p21-G13 DNA (rel) was treated with increasing amounts of S1 nuclease (lanes 2 ± 5). Control DNA was incubated in S1 nuclease reaction buer in the absence of the enzyme (lane 1). The sequence of the p53 binding site within the p21 promoter is shown and self-complementary regions within the site are indicated by arrows. Dots indicate those bases that would remain unpaired in case of formation of a cruciform by palindromic sequences within the site. Dots in parentheses mark bases sensitive to S1 nuclease, and located within the p53 binding site. Dotted lines align S1 nuclease sensitive bases with the unpaired bases in the proposed cruciform regulating the transactivation by p53, it still remains elusive what exactly confers selectivity to sequencespeci®c transactivation by p53. As the selective activation of the p21 and mdm2 genes has been demonstrated (Luna et al., 1997; Garcia et al., 1997; Saucedo et al., 1998; Arriola et al., 1999) , we in this report, analysed the possible in¯uence of promoter DNA topology on the activation of transcription from the p21 and mdm2 (P2) promoters by p53.
These studies were inspired by accumulating evidence from our and other laboratories indicating that SSDB of p53, a major prerequisite for its transactivation function, may be strongly in¯uenced by DNA conformation (discussed in the Introduction). Here we demonstrate that negative supercoiling inhibits binding to, and transactivation of the mdm2 (P2) promoter by p53 in vitro. This inhibition is due to local conformational distortions within the mdm2 (P2) promoter in supercoiled DNA, and the formation of an asymmetric secondary DNA structure that spans over the p53 response elements. This structure converts both p53 binding sites within the mdm2 (P2) promoter to a less preferred binding substrate as compared to regular B-DNA duplex in relaxed DNA, and thereby inhibits transactivation of the mdm2 (P2) promoter. The formation of a non-B-DNA structure within the mdm2 (P2) promoter strictly depends on DNA supercoiling, as relaxation of the DNA drastically abolished its sensitivity to SSN. Our DNA topology analyses showed that several bases within the p53 binding site from the p21 promoter were also sensitive to S1 nuclease. However, in contrast to the mdm2 (P2) promoter, the S1-sensitivity within the p21 promoter was only partially abolished in the absence of supercoiling and was sustained even after relaxation of the p21 promoter DNA with topoisomerase I. Whether the dierent sensitivity of the mdm2 (P2) or p21 promoters to S1 nuclease treatment after DNA relaxation re¯ects dierences in stability of the non-B-DNA structures formed under superhelical stress remains to be established. Also not known is the kind of non-B-DNA structures formed by each of these promoters in supercoiled DNA. However, our results indicate that the presence of a non-B-DNA conformation within the p21 promoter does not exert an inhibitory eect on SSDB and transactivation by p53 of this promoter. Thus, non-B-DNA conformations formed within two dierent promoters, p21 and mdm2 (P2), do not have a dierent impact on the interaction of p53 with the corresponding response elements. The DNA-conformation dependent recognition of these elements by p53 might provide a basis for the selective transactivation of these two genes by p53: the mdm2 gene cannot be activated when its P2 promoter is in a non-B-DNA conformation. Thus the P2 promoter has to be converted into a B-DNA conformation for the ecient activation of the mdm2 gene by p53. In contrast, the p21 promoter seems to be constitutively accessible for p53, independent of whether its promoter DNA is in B-or non-B-DNA conformation. Therefore, one has to postulate that p53-dependent transactivation of the p21 promoter is not regulated by promoter DNA topology, but rather is dependent on speci®c posttranslational modi®cations of the p53 protein, or regulated by the interaction of p53 with speci®c coactivators. Indeed, acetylation of p53 by p300 (Gu and Roeder, 1997) and association of p33ING with p53 (Garkavtsev et al., 1998) have been shown to speci®cally enhance p53-dependent transactivation of the p21 gene. The dierent eects of dierent non-B-DNA topologies in the mdm2 (P2) and p21 promoters on SSDB of p53 con®rm previous results from our laboratory, which suggested that various DNA topologies may have dierent or even opposing effects on SSDB by p53 (Kim et al., 1997) . Thus dierential sensitivity to dierent non-B-DNA conformations may be a means by which p53 distinguishes target genes that have to be activated from those that have to remain silent. An interesting aspect in this regard is the dierence in the functional organization of the mdm2 (P2) and the p21 promoters. The mdm2 (P2) promoter is highly specialized for the needs of p53-speci®c activation, insofar as p53-dependent transcripts are strictly produced from the mdm2 (P2) promoter, whereas p53 independent transcripts are produced from the mdm2 (P1) promoters (Zauberman et al., 1995) . Therefore, the strict dependence of the mdm2 (P2) promoter activity on the ability of p53 to activate Figure 4 Eect of DNA supercoiling on p53 transcriptional activation from the p21 and the mdm2 (P2) promoters. Saos-2 and G-130 cells were transiently transfected with 4 mg of supercoiled (white hatched bars), or spontaneously nicked (grey hatched bars), or topoisomerase I-relaxed (black bars) reporter plasmid DNA, with (+) or without (7) 0.1 mg of the cotransfected pCDNA3-wtp53 (Rowan et al., 1996) . Results are mean+s.e.m. (bars) shown for three (Saos-2) and four (G-130) independent experiments performed in triplicate this promoter will allow, on one hand, a stringent control over the p53-dependent expression of the mdm2 gene, and on the other hand, would not interfere with the regulated expression of this gene controlled by other, p53-independent pathways which utilize the mdm2 (P1) promoter. In contrast, the p21 promoter also mediates p53-independent induction of the p21 gene which involves transcriptional factors other than p53 (Macleod et al., 1995) . One therefore might speculate that a topology of the p21 promoter DNA that strongly prohibits p53 SSDB might also aect the interaction of other regulatory proteins with their speci®c cognate sites, thereby interfering with other, p53-independent functions of the p21 promoter.
In our experiments the`natural' superhelical density of naked DNA was sucient to support conformational transitions within the mdm2 (P2) promoter DNA in vitro. However, due to restraining of superturns by nucleosomal assembly, the superhelical density of DNA in vivo may not be high enough to induce conformational transitions in DNA. In this regard it is interesting that the P2 promoter region within the mdm2 gene was found to be constitutively free of nucleosomes (Xiao et al., 1998) . This on one hand could provide the superhelical density required for the formation of an inhibiting DNA conformation within the mdm2 (P2) promoter, and on the other hand facilitate the interaction of this DNA with architectural proteins that could support or stabilize regions with a distorted DNA topology. For instance, a connection between p53 and the DNA architectural protein HMG1 has recently been demonstrated (Jayaraman et al., 1998) . Not only can these proteins interact with each other in vitro, HMG1 also greatly enhances SSDB of p53, possibly through its ability to induce conformational changes in the DNA (Jayaraman et al., 1998) . Another DNA topology dependent protein that is able to interact with p53 is topoisomerase I (Gobert et al., 1996) . Interestingly, the interaction of p53 with topoisomerase I seems to enhance the DNA relaxing activity of topoisomerase I (Gobert et al., 1996) . As the ®ndings reported here suggest that the mdm2 (P2) promoter DNA has to be relaxed to be eciently bound by p53, it is tempting to speculate that p53 may recruit topoisomerase I, or other proteins modulating DNA conformation, to convert the DNA topology within the mdm2 (P2) promoter from one which prohibits binding to one that promotes it. Recently Arriola et al. (1999) demonstrated that transactivation of the mdm2 but not the p21 gene by p53 was selectively inhibited in the presence of the topoisomerase II poison etoposide. This ®nding is in good agreement with our hypothesis that the mdm2 (P2) promoter DNA has to be converted into a proper conformation (probably by topoisomerases) to allow transcriptional activation of the mdm2-gene by p53.
In summary our results demonstrate that the interaction of p53 with the mdm2 (P2) promoter may be regulated by DNA topology, as adoption of a non-B-DNA conformation within the mdm2 (P2) promoter exerts an inhibitory eect on SSDB and transactivation by p53 in vitro. We hypothesize that the ability to sense and discriminate between various DNA conformations may signi®cantly contribute to the selectivity of p53 in transactivating dierent target genes. Thus the presence of a speci®c sequence (consensus) as such may not be sucient to determine the interaction of p53 with its cognate sites, and DNA topology may be as important for such an interaction as sequence speci®city.
Materials and methods

Cell cultures, plasmids and DNA transfections
Saos-2 cells were obtained from the American Type Culture Collection. G-130 is a human glioblastoma cell line which does not express p53 due to gross rearrangements within the p53 gene (Anker et al., 1993) . Transcriptional activation by p53 was measured using the reporter constructs mdm2-G13 and p21-G13 containing the p53-responsive promoters of the mdm2 or the p21 gene, respectively. For construction of the mdm2-G13 and p21-G13 plasmids, DNA fragments containing a wild type human mdm2 (P2) promoter (350 bp) or the 72.2 kb human p21 promoter (2.3 kb) were subcloned from the pG12-hmdm2-luc (Zauberman et al., 1995) or the WWPluc (El-Deiry et al., 1993) plasmid, respectively, into the pG13 basic vector (Promega). Saos-2 and G-130 cells were transiently transfected by the calcium phosphate method using the Mammalian Transfection Kit (Stratagene). Transfection experiments were performed in triplicate in six-well plates using 4.5 mg of the reporter and 0.1 mg of the plasmid pCDNA3-wtp53 which expresses a human wild type p53 under the control of the cytomegalovirus (CMV) early region promoter (Rowan et al., 1996) . Cells were harvested 40 h after transfection, lysed on ice, and luciferase activity was measured in aliquots from each lysate. Dierences in the eciency of transfection among individual wells and plasmids were normalized by measuring the content of transfected DNA by dot blot hybridization and of total protein in the lysates used for the luciferase assay. Luciferase activity was expressed as the number of photons (c.p.m.) per mg of total protein6mg of transfected DNA. For the transfection experiments with relaxed DNA, 50 mg of supercoiled DNA were incubated with 100 units of topoisomerase I under conditions recommended by the supplier (Promega). The degree of relaxation was monitored by electrophoresis in a 0.8% agarose gels. After complete conversion of the supercoiled DNA fraction into relaxed topoisomers, the DNA was deproteinized by phenol-chloroform, ethanol precipitated and redissolved in the TE buer, pH 7.5. To account for DNA losses during puri®cation, DNA concentrations were adjusted to 1 mg/ml.
Protein puri®cation and DNA binding
Sf9 cells were infected with a recombinant baculovirus expressing wild type mouse p53, harvested 42 h post infection, and p53 protein was immunopuri®ed using a monoclonal antibody PAb421 anity column as described previously (Mummenbrauer et al., 1996) .
In both, EMSA and DNaseI protection experiments, preincubation and binding steps were performed in the same reaction buer, as previously described (Kim et al., 1997) . In DNaseI protection experiments 50 ml reaction mixtures were incubated at room temperature for 30 min followed by DNaseI digestion for 1 min at room temperature. The amounts of DNaseI were adjusted such that an even ladder was produced. After terminating the digestion reaction by adding DNaseI stop buer (100 mM Tris/HCl, pH 8.0; 1% SDS, 100 mM NaCl; 10 mM EDTA: 300 mM NaOAc; 200 mg/ ml proteinase K; 100 mg/ml yeast tRNA), the DNA was extracted with phenol/chloroform, precipitated with ethanol, and subjected to primer extension using the Klenow fragment of E. coli DNA polymerase (NEB) and the corresponding radiolabeled primers. The speci®c primer for the p21-G13 DNA was 5'-agcttgggcagcaggctgtgg-3'; the G11 primer (Promega) was used in the extension reaction with mdm2-G13 DNA.
Three hundred and four bp and 80 bp fragments containing p53 binding sites from the mdm2 (P2) or the p21 promoter were obtained by restriction digestion of the mdm2-G13 or p21-G13 plasmid DNA with AccI/MluI or HindIII/ MboII, respectively, and isolation of the fragments of interest from agarose gels. DNaseI protection assays with the isolated fragments was performed under the same reaction conditions as with supercoiled or relaxed plasmid DNAs, except that the amounts of DNA were adjusted such that equal molar amounts of target DNA was present in the binding reactions. For EMSA, the 304 bp or the 80 bp DNA fragments were dephosphorylated and radiolabeled with T4 polynucleotide kinase (NEB), and tested for binding using the same amounts as in the DNaseI protection experiments with linear DNA fragments.
Mapping of SSN-sensitive sites in the mdm2-G13 or p21-G13 DNA One mg of a supercoiled plasmid DNA was treated with 0.5 units of S1 nuclease (Promega) or with 0.01 units of mung bean nuclease (Promega), deproteinized with phenolchloroform, precipitated with ethanol and subjected to primer extension reactions. Equal amounts of radioactively labeled reaction products were loaded onto a 6% denaturing polyacrylamide gel and separated by electrophoresis in TBE buer, pH 8.0.
